1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)

Request For Quotation
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Suppliers list
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Guangzhou Ruidi Biotechnology Co., Ltd.  
Tel: 020-82099279 18988941402
Email: sales@ubiochem.com
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) manufacturers
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Basic information
Product Name:1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)
Synonyms:1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4);DB2115 tertahydrochloride
CAS:1366126-19-3
MF:C32H31ClN8O2
MW:595.1
EINECS:
Product Categories:
Mol File:1366126-19-3.mol
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Structure
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Chemical Properties
storage temp. 4°C, away from moisture
solubility DMSO : 10 mg/mL (14.19 mM; ultrasonic and warming and adjust pH to 2 with HCl and heat to 80°C)
form Solid
color Blue to purple
Safety Information
MSDS Information
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Usage And Synthesis
UsesDB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
Biological ActivityDB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
References[1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Preparation Products And Raw materials
Tag:1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)(1366126-19-3) Related Product Information
Doxorubicin hydrochloride Ruxolitinib 2-Deoxy-D-glucose Metformin Y-27632 Streptozotocin